<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-10591</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Orchid Chemicals &amp; Pharmaceuticals Ltd.</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">OCPL is an existing company with a capacity to make around 665tpa cephalosporins and other pharmaceutical products at Alathur near Chennai. More than 80% of its production is currently exported to Asia, the Middle-East. Small quantities also go  to Latin America. The turnover for the current year, ending March 2001, is estimated at US$89 million. The company is expecting  to earn a net profit of US$8.5 million. The project envisages expansion and diversification of the company&apos;&apos;s product mix and geographical reach so as to include developed countries and as to be able to sustain its business even after WTO regulations are in place.    With its support to OCPL, IFC will assist a medium-sized company to grow and transform itself from a bulk drug company into a well-integrated pharmaceutical company with strong capabilities in research and formulations business. In this way, OCPL would be in a position to sustain its growth and profitabilty and expand its operations into the regulated markets.    The project will significantly demonstrate how domestic companies can shift gears to meet emerging challenges (WTO induced regulatory reforms) and simultaneously use their strong comparative advantages, of low cost production and pool of trained scientists, to exploit the opportunities that are likely to be available in the domestic market.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN"></narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">ORCHID PHARMA LIMITED</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-10591" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2001-05-19" type="1"></activity-date>
  <activity-date iso-date="2001-05-22" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr D.S. Bhaskara Raju        Financial Controller         1, 6th Floor Crown Court, 34 Cathedral  Road Chennai 600 086, India        Tel: 91-44 - 811 1532        Fax: 91-44-811 49831</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <location ref="IN-India">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The company&apos;&apos;s headquarters are located at Chennai, Tamil Nadu, India. The project envisages expansion and diversification of the company&apos;&apos;s manufacturing and research activities that are located at Alathur, Irungatukottai and Sholinganallur, near Chenna in Tamilnadu, and at Aurangabad in Maharashtra, India. The three sites at Alathur, Irungatukottai and Aurangabad are located in special industrial areas, developed by the state industrial development corporations, and have adequate infrastructure by way of roads, telecommunications and power. Skilled manpower is easily available.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>22.0000000000 79.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">FA - Pharmaceuticals and Medicine</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $30.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2001-05-19"></period-start>
   <period-end iso-date="2001-06-30"></period-end>
   <value currency="USD" value-date="2001-05-19">0</value>
  </budget>
  <budget type="1">
   <period-start iso-date="2001-05-19"></period-start>
   <period-end iso-date="2001-06-30"></period-end>
   <value currency="USD" value-date="2001-05-19">30000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2001-05-19"></transaction-date>
   <value currency="USD" value-date="2001-05-19">30000000</value>
   <receiver-org>
    <narrative xml:lang="EN">ORCHID PHARMA LIMITED</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2001-05-19"></transaction-date>
   <value currency="USD" value-date="2001-05-19">0</value>
   <receiver-org>
    <narrative xml:lang="EN">ORCHID PHARMA LIMITED</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="510"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/10591/orchid-chemicals-pharmaceuticals-ltd">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
